Education
About Us
Working with TipRanks
Follow Us
Sonova Holding AG Unsponsored ADR (SONVY)
OTHER OTC:SONVY
SONVY Stock Chart & Stats
Day’s Range― - ―
52-Week Range$52.89 - $77.47
Previous CloseN/A
Volume1.17K
Average Volume (3M)14.63K
Market Cap
$16.76B
Enterprise Value$14.78B
Total Cash (Recent Filing)$513.80M
Total Debt (Recent Filing)CHF1.79B
Price to Earnings (P/E)28.5
Beta0.81
Next Earnings
Nov 14, 2025EPS Estimate
1.12Last Dividend Ex-Date
Jun 16, 2025Dividend Yield1.08%
Share Statistics
EPS (TTM)1.71
Shares Outstanding298,134,030
10 Day Avg. Volume512
30 Day Avg. Volume14,629
Financial Highlights & Ratios
PEG Ratio-3.94
Price to Book (P/B)5.14
Price to Sales (P/S)0.00
P/FCF Ratio22.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$67.00Price Target Upside14.98% Upside
Rating ConsensusHold
Number of Analyst Covering0
Sonova Holding AG News
PremiumCompany Announcements
Sonova Reports Strong Growth and CEO TransitionOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.01% Mutual Funds
<0.01% Other Institutional Investors
98.97% Public Companies and
Individual Investors
SONVY FAQ
What was Sonova Holding AG Unsponsored ADR’s price range in the past 12 months?
Sonova Holding AG Unsponsored ADR lowest stock price was $52.89 and its highest was $77.47 in the past 12 months.
What is Sonova Holding AG Unsponsored ADR’s market cap?
Sonova Holding AG Unsponsored ADR’s market cap is $16.76B.
When is Sonova Holding AG Unsponsored ADR’s upcoming earnings report date?
Sonova Holding AG Unsponsored ADR’s upcoming earnings report date is Nov 14, 2025 which is in 122 days.
How were Sonova Holding AG Unsponsored ADR’s earnings last quarter?
Sonova Holding AG Unsponsored ADR released its earnings results on May 09, 2025. The company reported $1.706 earnings per share for the quarter, beating the consensus estimate of $1.365 by $0.341.
Is Sonova Holding AG Unsponsored ADR overvalued?
According to Wall Street analysts Sonova Holding AG Unsponsored ADR’s price is currently Undervalued.
Does Sonova Holding AG Unsponsored ADR pay dividends?
Sonova Holding AG Unsponsored ADR pays a Annually dividend of $0.63 which represents an annual dividend yield of 1.08%. See more information on Sonova Holding AG Unsponsored ADR dividends here
What is Sonova Holding AG Unsponsored ADR’s EPS estimate?
Sonova Holding AG Unsponsored ADR’s EPS estimate is 1.12.
How many shares outstanding does Sonova Holding AG Unsponsored ADR have?
Sonova Holding AG Unsponsored ADR has 298,134,030 shares outstanding.
What happened to Sonova Holding AG Unsponsored ADR’s price movement after its last earnings report?
Sonova Holding AG Unsponsored ADR reported an EPS of $1.706 in its last earnings report, beating expectations of $1.365. Following the earnings report the stock price went up 3.164%.
Which hedge fund is a major shareholder of Sonova Holding AG Unsponsored ADR?
Currently, no hedge funds are holding shares in SONVY
Sonova Holding AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$67.00 (14.98% Upside)
$67.00 (14.98% Upside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.97%
12-Months-Change
Fundamentals
Return on Equity
21.18%
Trailing 12-Months
Asset Growth
4.13%
Trailing 12-Months
Company Description
Sonova Holding AG Unsponsored ADR
Sonova Holding AG is a leading global provider of innovative hearing care solutions. Headquartered in Switzerland, the company operates in the healthcare sector, focusing on the design, development, and distribution of hearing instruments, cochlear implants, and wireless communication solutions. Sonova's core products and services include a wide range of hearing aids, advanced cochlear implant systems, and audiological care services offered under well-known brands such as Phonak, Unitron, and Advanced Bionics.
SONVY Company Deck
SONVY Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed view with strong product launch feedback and solid sales growth, particularly in cochlear implants, but faced profitability pressures and challenging market conditions, especially in the Audiological Care segment.Read More>Technical Analysis
Baxter International
―
Cooper Co
―
Insulet
―
Smith & Nephew Snats
―
West Pharmaceutical Services
―